VALEANT PHARMACEUTICALS INTL's ticker is and the CUSIP is 91911K952.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $5,229,000 | -7.5% | 225,000 | -36.6% | 0.00% | 0.0% |
| Q1 2018 | $5,652,000 | -22.3% | 355,000 | +1.4% | 0.00% | -50.0% |
| Q4 2017 | $7,273,000 | -3.0% | 350,000 | -35.8% | 0.00% | 0.0% |
| Q3 2017 | $7,499,000 | +8.4% | 545,000 | +36.2% | 0.00% | 0.0% |
| Q2 2017 | $6,920,000 | +527.4% | 400,000 | +300.0% | 0.00% | – |
| Q1 2017 | $1,103,000 | -47.2% | 100,000 | -30.5% | 0.00% | -100.0% |
| Q4 2016 | $2,089,000 | -37.0% | 143,900 | +6.6% | 0.00% | 0.0% |
| Q3 2016 | $3,314,000 | +21.9% | 135,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $2,719,000 | -23.4% | 135,000 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $3,551,000 | -90.0% | 135,000 | -61.5% | 0.00% | -88.9% |
| Q4 2015 | $35,679,000 | +455.6% | 351,000 | +875.0% | 0.01% | +350.0% |
| Q3 2015 | $6,422,000 | – | 36,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pentwater Capital Management LP | 3,770,300 | $75,934,000 | 1.01% |
| SIMPLEX TRADING, LLC | 8,247 | $6,549,000 | 0.44% |
| Thrax Management, LLC | 100,000 | $2,014,000 | 0.31% |
| GROUP ONE TRADING, L.P. | 994,600 | $20,031,000 | 0.24% |
| CMT Asset Management Ltd | 192,800 | $3,883,000 | 0.20% |
| Citadel Advisors | 1,838,900 | $37,035,000 | 0.04% |
| JPMORGAN CHASE & CO | 135,000 | $2,719,000 | 0.00% |